Screener
Johnson & Johnson JNJ Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Johnson & Johnson’s reported figures.
Based on trailing twelve months.
The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000200406-26-000153
FAQ
- What is Johnson & Johnson's return on equity?
- Johnson & Johnson (JNJ) reported return on equity of 25.7% in Q2 2026.
- How has Johnson & Johnson's return on equity changed year-over-year?
- Johnson & Johnson's return on equity decreased by 14.8% year-over-year, from 30.2% to 25.7%.
- What is the long-term trend for Johnson & Johnson's return on equity?
- Over 2 years (2023 to 2025), Johnson & Johnson's return on equity has grown at a -14.8% compound annual growth rate (CAGR), from 48.3% to 35%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Johnson & Johnson's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude